GlaxoSmithKline (GSK) Australia has reported its 2017 results to the Australian Securities and Investment Commission (ASIC) for its pharmaceuticals and vaccines business  as well as GSK Consumer Healthcare (a joint venture with Novartis in 2017) and ViiV (a joint venture with Pfizer and Shionogi focused on HIV)